132 related articles for article (PubMed ID: 22659116)
21. Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification.
Gu J; Lu Y; Deng M; Qiu M; Tian Y; Ji Y; Zong P; Shao Y; Zheng R; Zhou B; Sun W; Kong X
Exp Mol Med; 2019 Jul; 51(7):1-14. PubMed ID: 31292436
[TBL] [Abstract][Full Text] [Related]
22. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification.
Narisawa S; Harmey D; Yadav MC; O'Neill WC; Hoylaerts MF; Millán JL
J Bone Miner Res; 2007 Nov; 22(11):1700-10. PubMed ID: 17638573
[TBL] [Abstract][Full Text] [Related]
23. Ectonucleotidase NTPDase3 is abundant in pancreatic β-cells and regulates glucose-induced insulin secretion.
Syed SK; Kauffman AL; Beavers LS; Alston JT; Farb TB; Ficorilli J; Marcelo MC; Brenner MB; Bokvist K; Barrett DG; Efanov AM
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1319-26. PubMed ID: 24085034
[TBL] [Abstract][Full Text] [Related]
24. Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.
Shayhidin EE; Forcellini E; Boulanger MC; Mahmut A; Dautrey S; Barbeau X; Lagüe P; Sévigny J; Paquin JF; Mathieu P
Br J Pharmacol; 2015 Aug; 172(16):4189-99. PubMed ID: 26031197
[TBL] [Abstract][Full Text] [Related]
25. Calcific aortic valve stenosis in old hypercholesterolemic mice.
Weiss RM; Ohashi M; Miller JD; Young SG; Heistad DD
Circulation; 2006 Nov; 114(19):2065-9. PubMed ID: 17075015
[TBL] [Abstract][Full Text] [Related]
26. Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue.
Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
Semin Thorac Cardiovasc Surg; 2001 Oct; 13(4 Suppl 1):99-105. PubMed ID: 11805957
[TBL] [Abstract][Full Text] [Related]
27. Pathogenetic mechanism of senile calcific aortic stenosis: the role of apoptosis.
Lee YS; Chou YY
Chin Med J (Engl); 1998 Oct; 111(10):934-9. PubMed ID: 11189244
[TBL] [Abstract][Full Text] [Related]
28. Pathobiology of Lp(a) in calcific aortic valve disease.
Mathieu P; Arsenault BJ; Boulanger MC; Bossé Y; Koschinsky ML
Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):797-807. PubMed ID: 28816078
[TBL] [Abstract][Full Text] [Related]
29. Prevention of calcific aortic valve stenosis-fact or fiction?
Cawley PJ; Otto CM
Ann Med; 2009; 41(2):100-8. PubMed ID: 18720096
[TBL] [Abstract][Full Text] [Related]
30. Pro-calcific responses by aortic valve interstitial cells in a novel in vitro model simulating dystrophic calcification.
Ortolani F; Rigonat L; Bonetti A; Contin M; Tubaro F; Rattazzi M; Marchini M
Ital J Anat Embryol; 2010; 115(1-2):135-9. PubMed ID: 21073003
[TBL] [Abstract][Full Text] [Related]
31. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of calcific aortic stenosis by statins: myth or reality?].
Peltier M; Tribouilloy C
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):818-22. PubMed ID: 17067101
[TBL] [Abstract][Full Text] [Related]
33. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
[TBL] [Abstract][Full Text] [Related]
34. Effect of statin treatment on aortic valve and coronary artery calcification.
Mohler ER; Wang H; Medenilla E; Scott C
J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase XII in valve interstitial cells promotes the regression of calcific aortic valve stenosis.
Bouchareb R; Côté N; Marie-Chloé-Boulanger ; Le Quang K; El Husseini D; Asselin J; Hadji F; Lachance D; Shayhidin EE; Mahmut A; Pibarot P; Bossé Y; Messaddeq Y; Boudreau D; Marette A; Mathieu P
J Mol Cell Cardiol; 2015 May; 82():104-15. PubMed ID: 25771146
[TBL] [Abstract][Full Text] [Related]
36. Statin therapy of calcific aortic stenosis: hype or hope?
Liebe V; Brueckmann M; Borggrefe M; Kaden JJ
Eur Heart J; 2006 Apr; 27(7):773-8. PubMed ID: 16399777
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
[TBL] [Abstract][Full Text] [Related]
38. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
Kaden JJ; Dempfle CE; Kiliç R; Sarikoç A; Hagl S; Lang S; Brueckmann M; Borggrefe M
Exp Mol Pathol; 2005 Feb; 78(1):36-40. PubMed ID: 15596058
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin reduces calcification in rat arteries and vascular smooth muscle cells.
Li H; Tao HR; Hu T; Fan YH; Zhang RQ; Jia G; Wang HC
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):798-802. PubMed ID: 20406203
[TBL] [Abstract][Full Text] [Related]
40. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function.
Bas A; Lopez I; Perez J; Rodriguez M; Aguilera-Tejero E
J Bone Miner Res; 2006 Mar; 21(3):484-90. PubMed ID: 16491297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
